Stay updated on KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Sign up to get notified when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.

Latest updates to the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 added; Revision: v3.2.0 removed. These are minor site version updates and do not affect the study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe government funding lapse notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check35 days agoChange DetectedThe new page shows a warning icon/banner and a newer last update date. Core study content such as eligibility criteria, primary outcomes, and intervention details appears unchanged.SummaryDifference0.5%

- Check64 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference4%

- Check71 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

- Check86 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removal of the 'Back to Top' link is a minor UI change.SummaryDifference0.2%

Stay in the know with updates to KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.